<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>23</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2018</Year><Month>02</Month><Day>03</Day></PubDate></Journal><title locale="en_US">The effect of testosterone gel on fertility outcomes in women with a poor response in in vitro fertilization cycles: A pilot randomized clinical trial</title><FirstPage>10754</FirstPage><LastPage>10754</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>03</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;In this study, the e?ect of testosterone gel administration during ovulation induction on the fertility rate was examined in women with a poor ovarian response in &lt;/span&gt;&lt;span class="fontstyle3"&gt;in vitro &lt;/span&gt;&lt;span class="fontstyle2"&gt;fertilization (IVF) cycles. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Te current study is a single?blinded, randomized clinical trial. Patients who met inclusion (Bologna) criteria were placed in the antagonist cycle group. Te patients were randomly divided into two groups each  included 25 participants treated with a placebo (lubricant gel, the controls)&lt;br /&gt;and testosterone gel (intervention). Fertility outcomes were compared between two study groups. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Te mean ± standard deviation (SD) age of intervention (41.04 ± 3.77) versus control group (39.69 ± 3.29) was not statistically di?erent. Te two studied groups were not statistically di?erent in terms of follicle?stimulating hormone; antral follicle count, IVF, anti?Mullerian hormone, and the duration of infertility. Te mean ± SD of oocyte 2.48 ± 1.64 versus 1.17 ± 1.27 and embryo 1.60 ± 1.58 versus 0.39 ± 0.58 in intervention group was signifcantly higher than control group (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.01). Te rate of pregnancy 16% versus 0% and embryo of quality&lt;br /&gt;A–B was signifcantly higher in intervention group than control (60% versus 17.4%, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.05). &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Te results of the current study showed that the testosterone gel has a signifcant impact on the fertility rate in women with a poor response in the IVF cycles. Further, randomized clinical trials with larger sample sized are recommended.&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10754</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10754/5643</pdf_url></Article></Articles>
